Andera Partners’s AgomAb Therapeutics NV AGMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.1M Hold
1,538,702
– – 9.72% 4
2026
Q2
$20M Hold
1,538,702
– – 9.67% 4
2026
Q1
$16.1M Buy
+1,538,702
New +$21.8M 9.12% 4

Other funds holding AGMB

Andera Partners's AGMB Position: Q3 2026 in Review

Andera Partners held its AgomAb Therapeutics NV (AGMB) position steady in Q3 2026 at 1,538,702 shares worth $17.1M. The position accounts for 9.72% of the portfolio, ranked #4.

Andera Partners first reported a position in AGMB in Q1 2026 and has held it in 3 quarters since. The position peaked at $20M in Q2 2026. 25 funds tracked by Wall St. Rank hold AGMB as of Q3 2026.

  • Andera Partners held 1,538,702 shares of AgomAb Therapeutics NV worth $17.1M as of Q3 2026.
  • Andera Partners left its AgomAb Therapeutics NV share count unchanged in Q3 2026.
  • AgomAb Therapeutics NV made up 9.72% of Andera Partners's portfolio in Q3 2026, its #4 holding.
  • Andera Partners first reported a position in AgomAb Therapeutics NV in Q1 2026 and has held it in 3 quarters since.
  • Andera Partners's AgomAb Therapeutics NV position peaked at $20M in Q2 2026.
  • 25 funds tracked by Wall St. Rank held AgomAb Therapeutics NV as of Q3 2026.

Based on Andera Partners's 13F filing for Q3 2026, filed 16 Oct 2026.